Looking for some ASX 200 shares to add to your portfolio? Then take a look at the three listed below.
Here’s why they are rated as buys currently:
Aristocrat Leisure Limited (ASX: ALL)
The first ASX 200 share to look at is Aristocrat Leisure. It is one of the world’s leading gaming technology companies. The last 12 months have been difficult for Aristocrat but it has bounced back strongly and looks well-positioned for growth. Especially now both its pokie machine and digital businesses are pulling together again. Citi is a fan of the company. It has a buy rating and $46.00 price target on its shares.
REA Group Limited (ASX: REA)
REA Group could be an ASX 200 share to consider. It is the leading player in real estate listings in the Australian market. This is a great position to be right now thanks to the housing market boom, which is underpinning solid listings growth. In addition to this, cost cutting, new revenue streams, price increases, and acquisitions look set to give its sales and earnings a boost in the coming years. Goldman Sachs is very bullish on REA Group. It recently put a buy rating and $198.00 price target on its shares.
ResMed Inc. (ASX: RMD)
Another ASX 200 share to look at is ResMed. It is one of the world’s leading medical device companies with a focus on sleep disorders. ResMed has been tipped for further strong growth over the 2020s thanks to its enormous addressable market, its industry-leading technology, and its digital health ecosystem. In respect to the latter, the company’s investment in digital health have given it an advantage over much of the competition and puts it in a strong position to benefit from the shift to home healthcare. Macquarie currently has an outperform rating and $34.85 price target on its shares.